EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro

Miranda Ortega, Eri Agena, Wenqiang Chen iD, Hong Cao, Sona Vasudevan iD, Narayan Shivapurkar, Mariaelena Pierobon, Jill P Smith iD

International Journal of Molecular Sciences · 03.12.2025 · 26 (23) · 11699

DOI: 10.3390/ijms262311699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.12.2025. Verfasst von Miranda Ortega und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC 20007, USA. Hauptthemen laut MEDLINE: Pancreatic Stellate Cells, Pancreatic Neoplasms, Apoptosis, Receptor, Cholecystokinin B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH/NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is characterized by an extensive fibrotic stroma largely driven by activated pancreatic stellate cells (PSCs)/fibroblasts, which also function to support tumor growth and metastasis. Cholecystokinin-B receptors (CCK-BRs) are expressed on pancreatic stellate cells (PSCs) and have emerged as a key regulator of PSC activation and tumor-stromal interactions. We hypothesized that disrupting CCK-BR function shifts PSCs to a more quiescent phenotype and reduces their pro-fibrotic and tumor-supportive activity to decrease growth of pancreatic cancer. Murine PSCs were genetically engineered with CRISPR-Cas9 to knockout the CCK-BR. In a series of experiments, the role of the CCK-BR expression was evaluated on cell migration, proliferation, differentially expressed genes, molecular signaling pathways, and in co-culture with murine pancreatic cancer epithelial cells. Next, primary human pancreatic stellate cells were treated with proglumide, a CCK-BR antagonist, to study the effects of pharmacologic blockade of the CCK-BR on cellular signaling and proliferative pathways by RNA sequencing. Knockout of the CCK-BR led to significant decreases in PSC activation and the ability to stimulate growth of pancreatic cancer cells in co-culture. Both genetic knockdown and pharmacologic blockade of the CCK-BR downregulated genes implicated in fibrosis, proliferation, fibroblast activation, and tumorigenesis, while genes implicated in apoptosis and tumor suppression were upregulated. Flow cytometry showed increased apoptosis markers in CCK-BR-knockout cells compared to controls. These experiments combine transcriptomic profiling with functional validation to provide a comprehensive analysis of how targeting CCK-BR interrupts the cross-communication between cancer cells and fibroblasts. Blockade or downregulation of the CCK-BR on pancreatic fibroblasts may provide a strategy to disrupt oncogenic signaling pathways and reprogram the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Stellate CellsPancreatic NeoplasmsApoptosisReceptor, Cholecystokinin BAnimalsHumansMiceCell ProliferationDown-RegulationSignal TransductionCell Line, TumorCoculture TechniquesGene Expression Regulation, NeoplasticCell MovementProglumide

Stichwörter der Autor:innen

cancer-associated fibroblastmolecular signaling pathwaystumor microenvironment

Substanzen

Receptor, Cholecystokinin BProglumide

Autor:innen und Institutionen

  • Departments of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC 20007, USA.
  • Department of Medicine, Georgetown University, Washington, DC 20007, USA.
  • Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA 20110, USA.

ORCID-Profile: Wenqiang Chen, Sona Vasudevan, Jill P Smith

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIH/NCI

Zitieren

APA

Ortega, M., Agena, E., Chen, W., Cao, H., Vasudevan, S., Shivapurkar, N., Pierobon, M., & Smith, J. P. (2025). Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro. International Journal of Molecular Sciences, 26(23), 11699. https://doi.org/10.3390/ijms262311699

Vancouver

Ortega M, Agena E, Chen W, Cao H, Vasudevan S, Shivapurkar N, et al. Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro. International Journal of Molecular Sciences. 2025;26(23):11699. doi:10.3390/ijms262311699

BibTeX
@article{Ortega2025,
  author = {Ortega, Miranda and Agena, Eri and Chen, Wenqiang and Cao, Hong and Vasudevan, Sona and Shivapurkar, Narayan and Pierobon, Mariaelena and Smith, Jill P},
  title = {Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {23},
  pages = {11699},
  doi = {10.3390/ijms262311699}
}
Kostenlos starten →